Sylogist Ltd. (TSE:SYZ - Free Report) - Equities researchers at Ventum Cap Mkts issued their Q1 2025 earnings estimates for Sylogist in a report issued on Thursday, March 13th. Ventum Cap Mkts analyst A. Ezzat forecasts that the company will post earnings per share of $0.01 for the quarter. The consensus estimate for Sylogist's current full-year earnings is $0.24 per share. Ventum Cap Mkts also issued estimates for Sylogist's Q2 2025 earnings at $0.03 EPS, Q3 2025 earnings at $0.06 EPS and Q4 2025 earnings at $0.08 EPS.
Sylogist Price Performance
Shares of TSE SYZ traded down C$0.20 during mid-day trading on Monday, reaching C$8.31. 11,091 shares of the company traded hands, compared to its average volume of 60,825. Sylogist has a fifty-two week low of C$8.09 and a fifty-two week high of C$11.60. The company has a debt-to-equity ratio of 47.19, a current ratio of 0.54 and a quick ratio of 0.51. The firm has a market cap of C$196.49 million, a PE ratio of 184.42 and a beta of 0.82. The stock has a fifty day simple moving average of C$9.49 and a 200-day simple moving average of C$10.09.
Sylogist Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 12th. Shareholders of record on Wednesday, March 12th were given a $0.01 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $0.04 annualized dividend and a yield of 0.48%. Sylogist's dividend payout ratio (DPR) is 88.77%.
Sylogist Company Profile
(
Get Free Report)
Sylogist Ltd., a software company, provides mission-critical software-as-a-service solutions in Canada, the United States, and the United Kingdom. The company offers SylogistMission constituent relationship management system, which includes donor management, fundraising, volunteer management, and program delivery; and enterprise resource management, such as accounting and financial management, grant and award management, budget management, payroll and human resources, analytics and reporting, and support and training.
Featured Articles
Before you consider Sylogist, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sylogist wasn't on the list.
While Sylogist currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
